# Estrella Immunopharma, Inc.: Form 8-K, filed Feb 2, 2024

- Company: [Estrella Immunopharma, Inc.](/companies/esla.md) (CIK 1844417)
- Form: 8-K
- Filed: 2024-02-02
- Accepted by EDGAR: Feb 2, 2024, 08:30 ET
- Period: 2024-01-30
- Accession: 0001213900-24-009325
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1844417/000121390024009325/ea192700-8k_estrella.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1844417/000121390024009325/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1844417/000121390024009325/ea192700-8k_estrella.htm

Filed Feb 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-009325. Last ingested by Listed: Nov 4, 2026, 07:37 ET. No prices; not investment advice.